These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 16943528

  • 21. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE, Karnon J, Smith RE, Johnston SR, Brandman J, Sung JC, Gross PE.
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [Abstract] [Full Text] [Related]

  • 22. Pediatric Hodgkin's disease.
    Oliapuram Jose B, Koerner P, Bertolone S, Patel CC, Spanos WJ, Paris KJ, Silverman CL, Yashar CM.
    J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
    [Abstract] [Full Text] [Related]

  • 23. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
    Devizzi L, Maffioli L, Bonfante V, Viviani S, Balzarini L, Gasparini M, Valagussa P, Bombardieri E, Santoro A, Bonadonna G.
    Ann Oncol; 1997 Mar; 8 Suppl 1():53-6. PubMed ID: 9187430
    [Abstract] [Full Text] [Related]

  • 24. Cost-Effectiveness Analysis of Routine Magnetic Resonance Imaging in the Follow-Up of Patients With Nasopharyngeal Carcinoma After Intensity Modulated Radiation Therapy.
    Zhou GQ, Wu CF, Zhang J, Mao YP, Tang LL, Chen L, Guo R, Ma J, Sun Y.
    Int J Radiat Oncol Biol Phys; 2018 Nov 15; 102(4):1382-1391. PubMed ID: 29804816
    [Abstract] [Full Text] [Related]

  • 25. Decision analysis on alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease.
    Ng AK, Weeks JC, Mauch PM, Kuntz KM.
    J Clin Oncol; 1999 Nov 15; 17(11):3577-85. PubMed ID: 10550157
    [Abstract] [Full Text] [Related]

  • 26. [Hodgkin's lymphoma and radiotherapy].
    Datsenko PV, Panshin GA.
    Vopr Onkol; 2015 Nov 15; 61(1):45-51. PubMed ID: 26016145
    [Abstract] [Full Text] [Related]

  • 27. Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis.
    Cheung MC, Prica A, Graczyk J, Buckstein R, Chan KK.
    Leuk Lymphoma; 2016 Aug 15; 57(8):1865-75. PubMed ID: 26758765
    [Abstract] [Full Text] [Related]

  • 28. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group.
    Engert A, Schiller P, Josting A, Herrmann R, Koch P, Sieber M, Boissevain F, De Wit M, Mezger J, Duhmke E, Willich N, Muller RP, Schmidt BF, Renner H, Muller-Hermelink HK, Pfistner B, Wolf J, Hasenclever D, Loffler M, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 Oct 01; 21(19):3601-8. PubMed ID: 12913100
    [Abstract] [Full Text] [Related]

  • 29. Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Muwakkit S, Geara F, Nabbout B, Farah RA, Shabb NS, Hajjar T, Khogali M.
    Radiat Oncol Investig; 1999 Oct 01; 7(6):365-73. PubMed ID: 10644060
    [Abstract] [Full Text] [Related]

  • 30. Prospective study of combined modality treatment or radiotherapy alone in the management of early-stage adult Hodgkin's disease.
    Yildiz F, Zengin N, Engin H, Güllü I, Barista I, Caglar M, Ozyar E, Cengiz M, Gürkaynak M, Zorlu F, Caner B, Atahan IL, Tekuzman G.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):839-46. PubMed ID: 15465201
    [Abstract] [Full Text] [Related]

  • 31. Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease.
    Ng AK, Bernardo MV, Silver B, Van Den Abbeele A, Stevenson MA, Fisher DC, Mauch PM.
    Int J Radiat Oncol Biol Phys; 2005 Jan 01; 61(1):175-84. PubMed ID: 15629609
    [Abstract] [Full Text] [Related]

  • 32. Treatment of childhood Hodgkin's disease with ABVD without radiotherapy.
    Behrendt H, Brinkhuis M, Van Leeuwen EF.
    Med Pediatr Oncol; 1996 Apr 01; 26(4):244-8. PubMed ID: 8600335
    [Abstract] [Full Text] [Related]

  • 33. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I, Ganser D, Freitag EM, Bohndorf W.
    Strahlenther Onkol; 1994 Sep 01; 170(9):516-23. PubMed ID: 7524173
    [Abstract] [Full Text] [Related]

  • 34. Cost effectiveness of chest computed tomography after lung cancer resection: a decision analysis model.
    Kent MS, Korn P, Port JL, Lee PC, Altorki NK, Korst RJ.
    Ann Thorac Surg; 2005 Oct 01; 80(4):1215-22; discussion 1222-3. PubMed ID: 16181843
    [Abstract] [Full Text] [Related]

  • 35. Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: a multi-institutional retrospective study.
    Castillo JJ, Bower M, Brühlmann J, Novak U, Furrer H, Tanaka PY, Besson C, Montoto S, Cwynarski K, Abramson JS, Dalia S, Bibas M, Connors JM, Furman M, Nguyen ML, Cooley TP, Beltran BE, Collins JA, Vose JM, Xicoy B, Ribera JM, HIV-Associated Hodgkin Lymphoma in the cART Era Study Group.
    Cancer; 2015 Feb 01; 121(3):423-31. PubMed ID: 25251326
    [Abstract] [Full Text] [Related]

  • 36. Cost-effectiveness of whole-body CT screening.
    Beinfeld MT, Wittenberg E, Gazelle GS.
    Radiology; 2005 Feb 01; 234(2):415-22. PubMed ID: 15670999
    [Abstract] [Full Text] [Related]

  • 37. Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial.
    Iannitto E, Minardi V, Gobbi PG, Calvaruso G, Tripodo C, Marcheselli L, Luminari S, Merli F, Baldini L, Stelitano C, Callea V, Petrini M, Angrilli F, Quarta G, Vallisa D, Molica S, Liardo E, Polimeno G, Brugiatelli M, Federico M.
    Clin Lymphoma Myeloma; 2009 Apr 01; 9(2):138-44. PubMed ID: 19406724
    [Abstract] [Full Text] [Related]

  • 38. [Five-year outcome of a new combination chemotherapy with CEA/ABVD for advanced Hodgkin's disease with poor prognosis].
    Kharchenko VP, Datsenko PV, Panyshin GA, Sotnikov VM, Mel'nik IuD.
    Vopr Onkol; 2006 Apr 01; 52(5):531-7. PubMed ID: 17168361
    [Abstract] [Full Text] [Related]

  • 39. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D, Jais JP, Desablens B, Berthou C, Casassus P, Moles MP, Delwail V, Gastinne T, Colonna P, Andrieu JM.
    Cancer; 2008 Feb 15; 112(4):846-55. PubMed ID: 18072259
    [Abstract] [Full Text] [Related]

  • 40. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
    Eich HT, Staar S, Gossmann A, Hansemann K, Skripnitchenko R, Kocher M, Semrau R, Engert A, Josting A, Franklin J, Krug B, Diehl V, Müller RP, German Hodgkin Study Group.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1121-7. PubMed ID: 15001253
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.